These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26827952)

  • 21. Vitamin D analogs, 20-Epi-22-oxa-24a,26a,27a,-trihomo-1alpha,25(OH)2-vitamin D3, 1,24(OH)2-22-ene-24-cyclopropyl-vitamin D3 and 1alpha,25(OH)2-lumisterol3 prime NB4 leukemia cells for monocytic differentiation via nongenomic signaling pathways, involving calcium and calpain.
    Berry DM; Meckling-Gill KA
    Endocrinology; 1999 Oct; 140(10):4779-88. PubMed ID: 10499538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale for active vitamin D and analogs in the treatment of osteoporosis.
    Nishii Y
    J Cell Biochem; 2003 Feb; 88(2):381-6. PubMed ID: 12520540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular disease in chronic kidney failure: is there a role for vitamin D analogs?
    Wu-Wong JR; Nakane M; Traylor L; Ruan X; Kroeger PE; Tian J
    Curr Opin Investig Drugs; 2005 Mar; 6(3):245-54. PubMed ID: 15816500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone effects of vitamin D - Discrepancies between in vivo and in vitro studies.
    Suda T; Takahashi F; Takahashi N
    Arch Biochem Biophys; 2012 Jul; 523(1):22-9. PubMed ID: 22107950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D Analogs with Nitrogen Atom at C2 Substitution and Effect on Bone Formation.
    Kittaka A; Takano M; Saitoh H
    Vitam Horm; 2016; 100():379-94. PubMed ID: 26827960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D and bone.
    Suda T; Ueno Y; Fujii K; Shinki T
    J Cell Biochem; 2003 Feb; 88(2):259-66. PubMed ID: 12520524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D and its analogs as anticancer and anti-inflammatory agents.
    Chen J; Tang Z; Slominski AT; Li W; Żmijewski MA; Liu Y; Chen J
    Eur J Med Chem; 2020 Dec; 207():112738. PubMed ID: 32829183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings.
    Verstuyf A; Verlinden L; Van Baelen H; Sabbe K; D'Hallewyn C; De Clercq P; Vandewalle M; Bouillon R
    J Bone Miner Res; 1998 Apr; 13(4):549-58. PubMed ID: 9556055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.
    Ono Y
    J Steroid Biochem Mol Biol; 2014 Jan; 139():88-97. PubMed ID: 24139874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
    Brown AJ; Slatopolsky E
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D: recent advances.
    DeLuca HF; Schnoes HK
    Annu Rev Biochem; 1983; 52():411-39. PubMed ID: 6311080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to minimize bone disease in renal failure.
    Martin KJ; González EA
    Am J Kidney Dis; 2001 Dec; 38(6):1430-6. PubMed ID: 11728986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel 9-Alkyl- and 9-Alkylidene-Substituted 1α,25-Dihydroxyvitamin D3 Analogues: Synthesis and Biological Examinations.
    Kulesza U; Plum LA; DeLuca HF; Mouriño A; Sicinski RR
    J Med Chem; 2015 Aug; 58(15):6237-47. PubMed ID: 26206427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Novel alkyl side chain sulfone 1alpha,25-dihydroxyvitamin D3 analogs: a comparison of in vitro antiproliferative activities and in vivo calcemic activities'.
    Usera AR; Dolan P; Kensler TW; Posner GH
    Bioorg Med Chem; 2009 Aug; 17(15):5627-31. PubMed ID: 19577932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eldecalcitol replaces endogenous calcitriol but does not fully compensate for its action in vivo.
    Saito H; Harada S
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():189-96. PubMed ID: 24291401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D analogs: therapeutic applications and mechanisms for selectivity.
    Brown AJ; Slatopolsky E
    Mol Aspects Med; 2008 Dec; 29(6):433-52. PubMed ID: 18554710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity.
    Barycki R; Sicinski RR; Plum LA; Grzywacz P; Clagett-Dame M; Deluca HF
    Bioorg Med Chem; 2009 Nov; 17(22):7658-69. PubMed ID: 19819702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
    J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Difluoromethyl analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: Design, synthesis, and preliminary biological evaluation.
    Posner GH; Suh BC; Petersen KS; Dolan P; Agoston ES; Kensler TW; Koh JT; Peleg S
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):213-21. PubMed ID: 17218093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel A-ring analogs of the hormone 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation.
    Posner GH; Lee SH; Kim HJ; Peleg S; Dolan P; Kensler TW
    Bioorg Med Chem; 2005 Apr; 13(8):2959-66. PubMed ID: 15781405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.